Literature DB >> 2031967

The value of BMT in AML patients in first remission. A statistician's view-point.

S Suciu.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2031967     DOI： 10.1007/bf01714898

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  2 in total

1.  Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemia.

Authors:  R Willemze; W E Fibbe; J C Kluin-Nelemans; J H Falkenburg; D J Richel; W G Peters; G J den Ottolander; A Brand; F E Zwaan
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

2.  Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation.

Authors:  J Hermans; S Suciu; T Stijnen; P Aegerter; N C Gorin; A Gratwohl; M Hayat; P Stryckmans; R Zittoun; F E Zwaan
Journal:  Eur J Cancer Clin Oncol       Date:  1989-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.